Astellas to Form Strategic Partnership with ClearPath to Build Vaccine Portfolio

News   Jan 07, 2014

 
Astellas to Form Strategic Partnership with ClearPath to Build Vaccine Portfolio
 
 
 

RELATED ARTICLES

BIA Separations appoints Pete Gagnon as Chief Scientific Officer

News

Appointment will drive new product and applications development.

READ MORE

Being Born During a Flu Pandemic May Increase Your Risk of Death During Another Flu Pandemic

News

While past exposure to influenza A viruses often builds immunity to similar, and sometimes different, strains of the virus, researchers are calling for more attention to exceptions to that rule.

READ MORE

Concept Life Sciences appoints New Group Programme Manager and US Head of Sales

News

Key leadership appointments support integration of the Group and expansion in the US market.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE